Avadel Pharmaceu (AVDL) Total Assets by Year
Avadel Pharmaceu closed fiscal year 2024 with $164.2M in total assets, $90.4M in total liabilities and $73.8M in shareholder equity. This represents a decrease of 0.3% from the prior fiscal year. The table below carries 15 fiscal years, from 2010 to 2024, and the quarters Avadel Pharmaceu has filed alongside them.
Annual figures, oldest first. Point at a bar to read its period.
AVDL Balance Sheet by Fiscal Year
Figures are as reported in USD. Each change compares the year with the year before it, and each column links to the filing it was taken from.
| Metric | FY2410-K | FY2310-K | FY2210-K | FY2110-K | FY2010-K | FY1910-K | FY1810-K | FY1710-K | FY1610-K | FY1510-K | FY1410-K | FY1310-K | FY1210-K | FY1110-K | FY1010-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $164.2M-0.3% | $164.7M+24.0% | $132.8M-46.3% | $247.3M-20.7% | $311.6M+105.8% | $151.4M-20.4% | $190.3M-24.9% | $253.3M+3.2% | $245.5M+14.1% | $215.1M+23.5% | $174.2M+49.9% | $116.3M-0.9% | $117.3M+69.0% | $69.4M-7.0% | $74.6M |
| Total Liabilities | $90.4M+17.4% | $77.0M-50.0% | $153.9M-8.9% | $169.0M+13.2% | $149.4M-17.3% | $180.6M-3.7% | $187.5M+11.8% | $167.7M-17.6% | $203.4M+39.4% | $145.9M-2.3% | $149.3M+19.4% | $125.1M+44.1% | $86.8M+119.2% | $39.6M+3.4% | $38.3M |
| Total Equity | $73.8M-15.8% | $87.7M+514.9% | -$21.1M-127.0% | $78.2M-51.8% | $162.3M+655.7% | -$29.2M-1150.3% | $2.8M-96.8% | $85.6M+103.4% | $42.1M-39.1% | $69.1M+176.3% | $25.0M+383.8% | -$8.8M-128.9% | $30.5M+2.4% | $29.8M-17.9% | $36.3M |
AVDL Balance Sheet by Quarter
Figures are as reported in USD. Each change compares the quarter with the same quarter a year earlier.
| Metric | Q3'2510-Q | Q2'2510-Q | Q1'2510-Q | Q4'2410-Q | Q3'2410-Q | Q2'2410-Q | Q1'2410-Q | Q4'2310-K | Q3'2310-Q | Q2'2310-Q | Q1'2310-Q | Q4'2210-K |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | $199.4M+26.0% | $187.2M+18.8% | $167.9M0.0% | $164.2M-0.3% | $158.3M-22.1% | $157.5M-21.6% | $167.9M+19.3% | $164.7M+24.0% | $203.1M+39.3% | $201.0M+27.2% | $140.7M-36.4% | $132.8M-46.3% |
| Total Liabilities | $101.2M+21.1% | $96.4M+10.6% | $93.9M+4.9% | $90.4M+17.4% | $83.6M-10.1% | $87.2M+51.0% | $89.5M-50.0% | $77.0M-50.0% | $93.0M-41.2% | $57.8M-64.2% | $178.9M+7.8% | $153.9M-8.9% |
| Total Equity | $98.2M+31.6% | $90.7M+29.1% | $74.1M-5.5% | $73.8M-15.8% | $74.7M-32.2% | $70.3M-50.9% | $78.4M+305.4% | $87.7M+514.9% | $110.1M+985.4% | $143.2M+4397.5% | -$38.2M-169.1% | -$21.1M-127.0% |
What total assets means
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders.
More Avadel Pharmaceu financials
Frequently Asked Questions
What was Avadel Pharmaceu's total assets in fiscal year 2024?
Avadel Pharmaceu closed fiscal year 2024 with $164.2M in total assets, $90.4M in total liabilities and $73.8M in shareholder equity.
How fast is Avadel Pharmaceu's total assets growing?
Avadel Pharmaceu (AVDL) total assets fell by 0.3% year over year, from $164.7M to $164.2M in fiscal year 2024.
How has Avadel Pharmaceu's total assets changed over the years?
Across the 15 fiscal years this page covers, Avadel Pharmaceu (AVDL) total assets went from $74.6M in fiscal year 2010 to $164.2M in fiscal year 2024.
What was Avadel Pharmaceu's total assets in the most recent quarter?
Avadel Pharmaceu (AVDL) reported $199.4M in total assets in Q3 2025. This represents an increase of 26.0% from the same quarter a year earlier.
What does total assets mean on a financial statement?
Total assets is everything the company owns on the balance sheet date, total liabilities is everything it owes, and the difference between them is the equity that belongs to shareholders. This page lists what Avadel Pharmaceu (AVDL) reported on that line in every period on record.